Privacy settings may have prevented some items from showing.
Please update your search criteria and try again. You need to be logged in.
The worldwide recognition of Juvenile myoclonic epilepsy (JME), or Janz Syndrome, has created confusion about the criteria, treatment in the different age groups, and lifestyle recommendations. Patients with JME still face suboptimal management.
In the past five years many studies in JME patients have provided new insights, which will be addressed in the International Conference on JME held at the Bel Air Hotel, The Hague, The Netherlands on October 26th - 28th 2012
When you attend, you will gain:
|
|
Call for Abstracts | |
Abstract submission deadline: July 20th 2012 The conference welcomes submissions on all JME topics, including but not limited to: - JME and treatment For more information please visit: www.juvenile-myoclonic-epilepsy.com |